it acts as a protective agent in cerebral ischemia models [10] . Additionally, it has been shown that the expression of Epo and EpoR is increased when brain injury occurs [11] . Epo exhibited a neuroprotective effect in studies of stroke and spinal cord injury in animal models [12] . For a recent review of this field see [13] .
The human neuroblastoma cell line, SH-SY5Y, and a rat pheochromocytoma cell line, PC12, have become popular cell models for studies of neuroprotection, neurotoxicity and neurodegenerative diseases [14, 15] . However, the molecular basis of Epo's neuroprotection is not well understood. Quantitative real-time polymerase chain reaction (qPCR) is a technique that enables the identification of the genes involved in Epo-induced neuroprotection on neural cell lines SH-SY5Y and PC12.
qPCR is a valuable method for the quantification of gene expression due to its high sensitivity, broad dynamic range, accuracy and speed. The method is based on measurement of PCR products after DNA amplification [16, 17] . Since the expression of genes varies among organisms, tissues and cells and also among experimental groups of the same origin, there is a need for a good, reliable normalization gene or genes [18] . However, no gold standard is available, and different normalization approaches have been used. In the case of cell lines, normalization has been based on cell number, RNA quantity or cDNA quantity. But because of the significant variability of these parameters (amount of starting material, enzymatic efficiency, transcriptional activity, presence of inhibitors), "house keeping genes" (HKG) have become routinely used as normalization factors [19, 20] .
The ideal endogenous control should be expressed constantly, in all tissues, and under different conditions. The choice of reference genes depends on the cells studied and has to be validated for each experiment; if not, the differences in expression levels of genes of interest (GOI) may not be appreciated or may be incorrect [17] . Commonly known HKGs are glyceraldehyde-3-phosphate dehydrogenase (GAPDH), beta actin (ACTB) and 18s ribosomal RNA (18s rRNA) [21] [22] [23] [24] [25] . But in recent years, many studies have shown that the expression levels of these genes may vary under specific conditions [26, 27] .
Therefore, the first step in our qPCR experiment was the identification of genes being stably expressed in cell lines SH-SY5Y and PC12 under chronic recombinant human erythropoietin (rHuEpo) treatment, which could be used as reference genes. In the present study, we have evaluated the expression of 32 HKGs in SH-SY5Y cells under chronic rHuEpo treatment using TaqMan expressed human plates. Gene expression in cell lines SH-SY5Y and PC12 during chronic rHuEpo treatment was also validated with real-time qPCR with the aim to (re)test the stability of the most commonly used reference genes and determine the gene expression of several genes of interest involved in Epo signaling. (Neorecormon, Roche, Basel, Switzerland) at final concentrations of 1, 2, 5 IU mL -1 for 6 weeks. Isolation of RNA was performed during treatment every 3 to 5 days. 36 samples were collected from SH-SY5Y and 44 from PC12 cells (Table 1) . Samples crossed out in Table 1 were collected but not tested due to poor RNA yield. At the time of RNA isolation, the cells were ~80% confluent. 
TaqMan Express Plate
TaqMan Express 96 well 32 format human reaction plates (TaqMan, Express Endogenous Control Plate, Gene Expression Assays, Applied Biosystems, California, USA) were used on three SH-SY5Y pooled cDNA samples. Three sample pools marked with I-III were prepared by mixing the equal amount of RNA from SH-SY5Y samples (Table 1) with the highest RNA yield and analyzed in one technical replicate. Pre-designed gene specific primers and hydrolysis probe sets enabled us to perform quantitative gene expression studies on cDNA. The reaction mix consisted of 10 μL of cDNA (final concentration of cDNA was 10 ng per 20 μL reaction) and of 10 μL TaqMan Gene Expression Master mixes. The run was performed on an Applied Biosystems 7500 Real Time PCR System. qPCR reaction steps were AmpErase UNG Activation at 50ºC for 2 minutes, AmpliTaq DNA Polymerase Activation at 95ºC for 10 minutes, 45 cycles of denaturation at 95ºC for 15 seconds and annealing at 60ºC for 1 minutes.
Real time qPCR
Real time quantitative polymerase chain reactions (qPCR) were performed using LighCycler 480I (Roche Applied Science, Basel, Switzerland) on a 384 well plate format with LightCycler SYBR Green I Master (Roche Applied Science). The PCR master mix consisted of 2.5 μL of SYBR Green I Master, 1.15 μL of RNAse free water, 0.6 μL of 300 nM primer mix and 0.75 μL of 4.16 time diluted cDNA in a total volume of 5 μL. All the samples were analyzed in three technical replicas. qPCR reaction steps were 10 minutes at 95ºC, 40 cycles for 10 seconds at 95ºC, 20 seconds at 60ºC and 20 seconds at 72ºC. Melting curve analysis was performed in a range of 65ºC to 95ºC.
Primers were designed using the Roche Universal ProbeLibrary (Tables 2 and 3 ). They were designed to be intron-spanning, when possible, to minimize inaccuracies due to genomic DNA. All primers were validated on a series of cDNA dilutions to verify the presence of a gene specific peak and the absence of primer dimers.
Data analysis
Statistical analysis of data values was done using GraphPad Prism 5.0 (GraphPad software) and Windows Excel (Windows). For stability comparison of candidate reference genes, geNorm (http://medgen. ugent.be/~jvdesomp/geNorm/), NormFinder software (http://www.mdl.dk/publicationsnormfinder.htm) and BestKeeper (http://gene-quantification.com/bestkeeper. html) and EqPCR Wizard were used.
Results and discussion

Material for qPCR
Cell lines SH-SY5Y and PC12 were untreated or treated with rHuEpo (1, 2, 5 IU mL -1 ) for up to 6 weeks. During the time course of treatment, 36 samples from SH-SY5Y and 44 from PC12 cells were collected (Table 1) followed by isolation of total RNA, cDNA synthesis and TaqMan or SYBR Green real-time qPCR analysis.
Expression analysis of the candidate reference genes
Expression analysis of 32 reference/HKGs was performed on TaqMan Express Human plate in order to find the most stable genes during chronic rHuEpo treatment of SH-SY5Y cells. Analysis was performed on three pooled samples of RNA isolated from SH-SY5Y cells marked with I-III in Table 1 . Average quantification cycle (Cq) and standard deviation (SD) were calculated and are shown in Table 4 . Genes that show low SD are assumed to be more stably expressed in rHuEpo treated conditions compared to genes with higher SD.
Selection of reference genes for quantitative real-time PCR evaluation of chronic erythropoietin treatment effect on the SH-SY5Y and PC12 cells
The predicted most stably expressed genes were UBC, ELF1 and RPLP; the stability of RPLP was assessed further.
Expression analysis of the selected reference genes and genes of interest
The expression of one of the most stably expressed genes on TaqMan plates (RPLP), two most common used reference genes according to the literature (GAPDH and ACTB) [20, 31, 32] and six GOI (genes of interest) involved in Epo signal transduction (Table 2) were (re)evaluated with qPCR on 35 SH-SY5Y samples (Table 1) . In PC12, the expression of three most common used reference genes according to the literature (Gapdh, CycA and Ywhaz) [20, 31, 32] and seven GOI involved in Epo signal transduction (Table 3) were evaluated with qPCR on 41 samples (Table 1) . Low variability of quantification cycle (Cq) of tested GOI on each cell line shows high stability of our qPCR experiment (Fig. 1) . The expression of EPO and STAT5A in SH-SY5Y cells and Epo in PC12 cells was too low for further analysis.
Evaluation of expression stability
Evaluation of expression stability of four GOI in SH-SY5Y cells, six GOI in PC12 cells and three HKG in both cell lines was performed with three independent software programs. The geNorm uses a pair-wise comparison; co-regulated genes belonging to the same system with a similar expression profile get a high score. It ranks potential reference genes according to their expression stability. The software calculates the normalization factor (NF), which can be directly used for normalization of qPCR data. NormFinder ranks the genes on a model based approach and calculates a stability value According to geNorm, the 3 most stable genes with high average expression stability in SH-SY5Y samples are RPLP, STAT5B and EPOR, while in PC12 samples they are Akt1, Stat5a and CycA (Figs. 2A, 2E ). Among these genes, we can find HKG as well as GOI. GeNorm also evaluates the number of reference genes that should be used for normalization. The value V (pairwise variations) in the SH-SY5Y samples is the lowest in V2/3 and rises in V3/4 when an additional fourth gene is selected (Fig. 2B) , indicating that not more than 3 genes should be used for normalization. However, based on the low difference in average expression stability (M) between selected 3 genes ( Fig. 2A) , the normalization factor could be equally calculated from the 2 (RPLP, STAT5B) or 3 most stable genes (RPLP, STAT5B, EPOR). Pairwise variations in PC12 samples dramatically drop between V2/3 and V3/4 indicating that 4 genes would be the appropriate number (Akt1, Stat5a, CycA and Ywhaz) (Fig. 2F) . However based on the lower difference in average expression stability (M) between the 3 rd and 4 th genes (Fig. 2E) , the normalization factor could be equally calculated from the 3 most stable genes (Akt1, Stat5a and CycA).
The average expression stability was also performed with geNorm separately on untreated and Epo treated (5 IU mL -1 ) samples with the aim of determining if Epo treatment has any influence on the selection of the most stably expressed genes. Results show that there is no major difference in the selection of the most stable genes; the only difference is in the order of the proposed genes (data not shown). In SH-SY5Y untreated samples, EPOR, RPLP and STAT5B were proposed, while in Epo treated samples, EPOR, STAT5B and RPLP were proposed. In PC12 untreated samples, Akt, Stat5a and Ywhaz were selected, while in Epo treated samples Akt, Ywhaz and Stat5a were selected.
Ranking of genes by NormFinder is made on the stability value calculated from the combined estimate of intra-and inter-group values. Most stable are genes with a low stability value. In SH-SY5Y cells, these are STAT5B, RPLP and EPOR, while in PC12 cells, they are Akt1, Stat5a and Ywhaz (Fig. 2C, 2G ).
The last software or program used for reference gene determination was BestKeeper. This software uses average CP values for the calculation of the most stable genes used for normalization. Low SD of the CP values means that the gene could be used as a reference gene. In SH-SY5Y cells, this is RPLP followed by STAT5B and EPOR (Fig. 2D) . While in PC12 cells, CycA, Ywhaz, Stat5a and Akt have almost the same SD of CP (Fig. 2H) . Therefore, all three genes in SH-SY5Y and four genes in PC12 are suitable for normalization.
Reference gene selection
Real-time quantitative PCR is an accurate and reproducible method enabling evaluation of erythropoietin treatment on the level of gene expression. However, correct biological interpretation of qPCR data requires an appropriate normalization procedure, including selection of stable reference genes. Since Epo acts through several signaling pathways and modulates expression of several genes [34], we consider it important to note that some housekeeping genes (HKGs) may also be altered under Epo treatment. Previous results on Epo treated human breast cancer cell lines suggested that common HKGs are not stably expressed under these conditions (personal communications S. Berne). Therefore identification of HKGs under Epo treatment was performed with the aim of defining genes appropriate for normalization.
In this study, we analyzed the expression stability of several HKGs in Epo treated human SH-SY5Y cells with the aim of finding suitable reference genes for qPCR data analysis. Additionally, we analyzed the expression stability of the most commonly used HKGs and selected genes of interest (GOI), involved in Epo signal transduction, in human SH-SY5Y cells and rat PC12 cells during 6 weeks of rHuEpo treatment.
In order to find the most appropriate HKGs, experiments with TaqMan human Express Endogenous Control Plate were done on SH-SY5Y pooled samples. The experiments predict that among 32 genes, UBC, Selection of reference genes for quantitative real-time PCR evaluation of chronic erythropoietin treatment effect on the SH-SY5Y and PC12 cells ELF1 and RPLP are the most stably expressed genes in Epo treated samples (Table 4) . According to the literature, RPLP, GAPDH and ACTB are among the most commonly used endogenous controls in SH-SY5Y, all three also being present on TaqMan human Express Endogenous Control Plate [20, 31, 32] . While RPLP was confirmed to be an adequate gene for data normalization, GAPDH and ACTB expression fluctuates and, therefore, should not be used as reference genes under this treatment condition.
To confirm the results obtained on the pooled samples on TaqMan plates, the expression of RPLP, GAPDH and ACTB was re-evaluated with qPCR on all SH-SY5Y samples together with six genes involved in Epo signal transduction (Table 2) . In PC12 cells, the expression of the three most commonly used genes, according to the literature (Gapdh, CycA and Ywhaz) [20, 31, 32] , and seven genes involved in Epo signal transduction (Table 3) were evaluated. When comparing the data obtained with GeNorm, NormFinder and BestKeeper, we conclude that all three programs gave very similar results. We suggest the use of geNorm software, as it provides information on the stability of genes as well as information on the number of appropriate genes, to be used for normalization.
In the case of SH-SY5Y cells, RPLP, STAT5B and EPOR genes were always selected as the most suitable for normalization. According to geNorm the normalization to 2 most stable genes (RPLP and STAT5B) is also sufficient. Interestingly, only RPLP is a HKG, while STAT5B and EPOR are GOI. The selection of RPLP confirms the data obtained by TaqMan. This result also indicates that chronic rHuEpo treatment does not affect the expression level of two genes involved in Epo signal transduction, STAT5B and EPOR.
Similar results were obtained for PC12 cells. However, we selected the HKGs using data from the available literature (CycA, Ywhaz and Gapdh) [20, 31, 32] . All three programs suggested Stat5a and Ywhaz as a second and/or third choice. The difference in the results lay in the calculation of the most stable gene. In the case of geNorm and NormFinder, Akt1 was selected as the most stable, but in the case of BestKeeper it was CycA. According to geNorm, 3 most stable genes (Akt1, Stat5a and CycA) would be the appropriate number for normalization.
Normalization with geNorm and GAPDH factor
In order to show the effect of the normalization procedure on data interpretation, we analyzed two genes (JUN in SH-SY5Y, EpoR in PC12) with two separate normalization factors (Fig. 3) (Fig. 3A) , while the expression of EpoR appears to be increased during the first two weeks of Epo treatment (Fig. 3C) . The second normalization was performed with GAPDH, one of the most often selected normalization factors. Normalization to GAPDH results in a very unstable relative gene expression of both, JUN and EpoR during the entire treatment period (Figs. 3B,  3D ).
Influence of normalization factor on data interpretation
Normalization is the crucial step in qPCR data analysis; this is shown with two distinct approaches to the JUN and EpoR expression profile interpretation (Fig. 3) . If an inappropriate normalization approach is selected, results and biological interpretation can be misleading.
When normalization is performed with the three genes, determined by geNorm software to be the most stably expressed genes, the expression level of JUN in SH-SY5Y cells is not influenced by Epo treatment, while the expression of EpoR in PC-12 cells seems to be affected only at the beginning of treatment. However, when normalization is performed with only GAPDH, the expression level varies during the whole period of treatment. In addition, compared to other genes, the expression level of GAPDH in both cell lines is very high (Cq under 20, Fig. 1 ), which may additionally lower the stability of results. Zhou and colleagues have also shown that Gapdh is not recommended as a normalization factor when PC12 cells are treated with various pharmacological agents [33] . If the normalization of JUN and EpoR is performed only on GAPDH (Figs. 3B, 3D) , the results lead to an incorrect interpretation that these two genes are differentially expressed under rHuEpo treatment. It was previously shown that the expression of several genes varies during rHuEpo treatment [34] [35] [36] [37] . However, the interpretation of these data may need to be re-evaluated as quantification was performed with a single HKG (GAPDH, ACTB). Choosing the appropriate number of HKGs and the suitable software for evaluation and normalization are crucial steps adequate qPCR data interpretation.
Conclusions
We determined that the most commonly used reference gene, GAPDH, is not the most suitable gene for qPCR normalization of chronic rHuEpo treated SH-SY5Y and K. Španinger, A. J. Sytkowski, N. Debeljak PC12 cells. This was demonstrated using TaqMan human Express Endogenous Control Plate and qPCR analysis of selected genes. Epo alters the expression of several genes, including HKGs. It is very important that a careful selection of adequate reference genes is performed before qPCR normalization analysis. We propose RPLP, UBC and ELF1 in SH-SY5Y cells and CycA and Ywhaz in PC12 cells as reference genes suitable for normalization during chronic rHuEpo treatment.
